![Thomas Ohrt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/08/2024
Thomas W Ohrt is currently the Chief Financial Officer at Vitro Biopharma, Inc. He previously worked as the President & Chief Financial Officer at Formation Energy LP from 2013 to 2018.
He completed his undergraduate degree at Illinois State University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 29/01/2024 | 0 ( -.--% ) | - $ | 31/08/2024 |
| Empresas | Cargo | Inicio |
|---|---|---|
| VITRO DIAGNOSTICS, INC. | Director Financiero/CFO | 22/01/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
Formation Energy LP
 Formation Energy LP Financial ConglomeratesFinance Invests in oil and gas projects | Director Financiero/CFO | 01/10/2018 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Vitro Biopharma, Inc.
 Vitro Biopharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops cell therapies for autoimmune diseases and inflammatory disorders | Health Technology |
Illinois State University
 Illinois State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Formation Energy LP
Formation Energy LP Financial ConglomeratesFinance Invests in oil and gas projects | Finance |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
